Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026)
Bio-Rad Laboratories' (BIO) quarterly Non-Current Assets came in at $6.8 billion in Q1 2026, up 368.06% year-on-year from $1.5 billion in Q1 2025, and down 10.72% on a QoQ basis from $7.7 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Non-Current Assets data on file, last reported at $6.8 billion in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 368.06% year-over-year to $6.8 billion in Q1 2026; TTM through Mar 2026 was $18.6 billion, a 1015.69% increase from a year earlier, with the FY2025 full-year figure at $7.7 billion, up 21.1% from the prior year.
- Non-Current Assets for Q1 2026 stood at $6.8 billion, down from $7.7 billion in the prior quarter.
- Over the last five years, Non-Current Assets for BIO reached as high as $11.1 billion in Q1 2022 and fell as low as -$3.2 billion in Q4 2022.
- Historically, Non-Current Assets has averaged $3.9 billion across 5 years, with a median of $6.8 billion in 2026.
- Across the five-year window, Non-Current Assets slumped 134.58% in 2024 and surged 368.06% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at -$3.2 billion in 2022, then advanced by 19.07% to -$2.6 billion in 2023, then soared by 347.88% to $6.3 billion in 2024, then increased by 21.1% to $7.7 billion in 2025, then declined by 10.72% to $6.8 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $6.8 billion in Q1 2026, $7.7 billion in Q4 2025, and $6.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | 6.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.67 Bn |
| Sep 30, 2025 | 6.85 Bn |
| Jun 30, 2025 | -2.80 Bn |
| Mar 31, 2025 | -2.55 Bn |
| Dec 31, 2024 | 6.33 Bn |
| Sep 30, 2024 | -2.75 Bn |
| Jun 30, 2024 | -3.06 Bn |
| Mar 31, 2024 | -2.57 Bn |
| Dec 31, 2023 | -2.56 Bn |
| Sep 30, 2023 | 8.75 Bn |
| Jun 30, 2023 | 8.84 Bn |
| Mar 31, 2023 | 10.39 Bn |
| Dec 31, 2022 | -3.16 Bn |
| Sep 30, 2022 | 8.92 Bn |
| Jun 30, 2022 | 9.43 Bn |
| Mar 31, 2022 | 11.07 Bn |
| Dec 31, 2021 | -1.78 Bn |
| Sep 30, 2021 | 17.49 Bn |
| Jun 30, 2021 | 12.83 Bn |